Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Possible pulmonary cryptococcosis in a patient with Crohn's disease during anti-tumor necrosis factor-alpha treatment: a case report and literature review.

Takazono T, Izumikawa K, Yoshioka S, Matsuo N, Yamakawa M, Suyama N, Kohno S.

Jpn J Infect Dis. 2012;65(5):461-4. No abstract available.

2.

Asymptomatic pulmonary cryptococcosis in a patient with Crohn's disease on infliximab: case report.

Hirai F, Matsui T, Ishibashi Y, Higashi D, Futami K, Haraoka S, Iwashita A.

Inflamm Bowel Dis. 2011 Jul;17(7):1637-8. doi: 10.1002/ibd.21564. Epub 2010 Dec 3. No abstract available.

PMID:
21674724
3.

Late onset of Crohn’s disease in familial Mediterranean fever: the necessity of anti-TNF treatment.

Kosmidou M, Mpolotsis V, Christou L, Tsianos EV.

J Dig Dis. 2014 Feb;15(2):102-4. No abstract available.

PMID:
24734305
4.

A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.

Feagan BG, Sandborn WJ, Baker JP, Cominelli F, Sutherland LR, Elson CO, Salzberg BA, Archambault A, Bernstein CN, Lichtenstein GR, Heath PK, Cameron S, Hanauer SB.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):373-84.

5.

Algorithm for the treatment of Crohn's disease: incorporation of emerging therapies.

Souney PF.

Am J Gastroenterol. 2000 Sep;95(9):2381-3. Review. No abstract available.

PMID:
11007248
6.
7.

Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?

Sorrentino D, Nash P, Viladomiu M, Hontecillas R, Bassaganya-Riera J.

Inflamm Bowel Dis. 2014 Apr;20(4):757-66. doi: 10.1097/01.MIB.0000442680.47427.bf. Review. No abstract available.

PMID:
24572206
8.

Pulmonary cryptococcosis in a patient with Crohn's disease treated with prednisone, azathioprine and adalimumab: exposure to chicken manure as a source of contamination.

Fraison JB, Guilpain P, Schiffmann A, Veyrac M, Le Moing V, Rispail P, Le Quellec A.

J Crohns Colitis. 2013 Feb;7(1):e11-4. doi: 10.1016/j.crohns.2012.04.016. Epub 2012 May 29.

PMID:
22647638
9.

Treatment of Crohn's disease at the turn of the century.

Bickston SJ, Cominelli F.

N Engl J Med. 1998 Aug 6;339(6):401-2. No abstract available.

PMID:
9691110
10.

[Anti-TNF therapy and Crohn's disease].

Peyrin-Biroulet L.

Gastroenterol Clin Biol. 2008 May;32(5 Pt 1):478-81. doi: 10.1016/j.gcb.2008.03.004. Epub 2008 Apr 24. French. No abstract available.

11.

[From research to clinic: The case of Crohn's disease and Tumor Necrosis Factor].

Pellicano R.

Minerva Gastroenterol Dietol. 2000 Jun;46(2):131-8. Review. Italian. No abstract available.

PMID:
19320082
12.

Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.

Bauditz J, Lochs H, Schreiber S.

N Engl J Med. 1998 Jan 29;338(5):334. No abstract available.

13.

Salt ageusia in a patient with Crohn's disease treated with tumor necrosis factor antagonists.

Collet S, Rombaux P, Rahier JF.

Inflamm Bowel Dis. 2013 Apr;19(5):E73-4. doi: 10.1097/MIB.0b013e3182802b9c. No abstract available.

PMID:
23407044
14.

Crohn's disease in common variable immunodeficiency: treatment with antitumor necrosis factor alpha.

Nos P, Bastida G, Beltran B, Aguas M, Ponce J.

Am J Gastroenterol. 2006 Sep;101(9):2165-6. No abstract available.

PMID:
16968516
15.

Anti-tumor necrosis factor-alpha (TNF-alpha) treatment strategies in Crohn's disease.

Reimund JM, Ratajczyk J, Sola B, Justum AM, Muller CD.

Recent Pat Inflamm Allergy Drug Discov. 2007 Feb;1(1):21-34. Review.

PMID:
19075963
16.

Anti-TNFalpha therapy in a rare case of Crohn's disease: still a panacea.

Verburg R, Zelissen P, Rothova A, Siersema PD, Oldenburg B.

Inflamm Bowel Dis. 2008 Oct;14(10):1457-60. doi: 10.1002/ibd.20443. No abstract available.

PMID:
18383178
17.

Early onset primary pulmonary cryptococcosis in a renal transplant patient.

Tarai B, Kher V, Kotru P, Sabhikhi A, Barman P, Rattan A.

Indian J Med Microbiol. 2010 Jul-Sep;28(3):250-2. doi: 10.4103/0255-0857.66489.

18.

Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease.

Sorrentino D, Terrosu G, Vadalà S, Avellini C.

Digestion. 2007;75(1):22-4. Epub 2007 Apr 10. No abstract available.

19.

Sarcoidosis during infliximab therapy for Crohn's disease.

Takahashi H, Kaneta K, Honma M, Ishida-Yamamoto A, Ashida T, Kohgo Y, Ohsaki Y, Iizuka H.

J Dermatol. 2010 May;37(5):471-4. doi: 10.1111/j.1346-8138.2010.00861.x.

PMID:
20536653
20.

Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.

de Rossi TM, Krauss N, Voll RE, Nägel A, Weidenhiller M, Konturek PC, Hahn EG, Raithel M.

Digestion. 2008;78(4):195-200. doi: 10.1159/000187637. Epub 2008 Dec 22.

PMID:
19122456

Supplemental Content

Support Center